0.0586
0.00136 (2.38%)
0.00136 (2.38%)
Upgrade to Real-Time
Market Closed
Best deals to access real time data! |
|
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
|
|
Canna Trader Pro
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Elite Pharmaceuticals Inc (QB) | ELTP | OTCMarkets | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| 0.00136 | 2.38% | 0.0586 | 15:59:26 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 0.055 | 0.0521 | 0.06 | 0.0586 | 0.05724 |
| Bid Price | Ask Price | Spread | News | |
|---|---|---|---|---|
| 0.056 | 0.06 | 0.004 | - | - |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 130 | 2,678,645 | $ 0.054519 | $ 146,037 | - | 0.048 - 0.10 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 15:59:26 | 1,793 | $ 0.0586 | USD |
Elite Pharmaceuticals (QB) Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 59.14M | 1.01B | 793.80M | $ - | $ - | - | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| 3.46k | $ - | 0.00% | - | - |
Elite Pharmaceuticals (QB) News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ELTP Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.06 | 0.064 | 0.0521 | 0.0591254 | 879,940 | -0.0014 | -2.33% |
| 1 Month | 0.0695 | 0.0924 | 0.0521 | 0.0700483 | 2,504,845 | -0.0109 | -15.68% |
| 3 Months | 0.05425 | 0.0924 | 0.04805 | 0.0626857 | 1,745,830 | 0.00435 | 8.02% |
| 6 Months | 0.0765 | 0.0924 | 0.048 | 0.0619318 | 1,340,661 | -0.0179 | -23.4% |
| 1 Year | 0.08 | 0.10 | 0.048 | 0.0671909 | 1,053,855 | -0.0214 | -26.75% |
| 3 Years | 0.105 | 0.141 | 0.0333 | 0.0799146 | 848,335 | -0.0464 | -44.19% |
| 5 Years | 0.30 | 0.395 | 0.0333 | 0.1287906 | 970,255 | -0.2414 | -80.47% |
Elite Pharmaceuticals (QB) Description
| Elite Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on the development, manufacturing, and packaging of niche generic products, which are then distributed by exclusive marketing partners. Elite specializes in oral sustained and controlled release drug products that have high barriers to entry. Elite owns generic products which have been licensed to TAGI Pharma, Glenmark Pharmaceuticals, Inc., USA., and Lannett Company, Inc. Elite currently has eleven approved generic products, two which are pending launch, another two generic products are filed with the FDA, and an NDA filed for SequestOx(TM). Elite operates a GMP and DEA registered facility for research, development, and manufacturing located in Northvale, NJ. Learn more at www.elitepharma.com. |
